Oga T - Search Results

1

Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure.

Takahashi K, Chin K, Nakamura H, Morita S, Sumi K, Oga T, Matsumoto H, Niimi A, Fukuhara S, Yodoi J, Mishima M. Takahashi K, et al. Among authors: oga t. Antioxid Redox Signal. 2008 Apr;10(4):715-26. doi: 10.1089/ars.2007.1949. Antioxid Redox Signal. 2008. PMID: 18199002

2

Comparison of the responsiveness of different disease-specific health status measures in patients with asthma.

Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Oga T, et al. Chest. 2002 Oct;122(4):1228-33. doi: 10.1378/chest.122.4.1228. Chest. 2002. PMID: 12377846

3

Health status measured with the CRQ does not predict mortality in COPD.

Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Ikeda A, Mishima M. Oga T, et al. Eur Respir J. 2002 Nov;20(5):1147-51. doi: 10.1183/09031936.02.00303702. Eur Respir J. 2002. PMID: 12449167 Free article.

4

Relationship between different indices of exercise capacity and clinical measures in patients with chronic obstructive pulmonary disease.

Oga T, Nishimura K, Tsukino M, Hajiro T, Ikeda A, Mishima M. Oga T, et al. Heart Lung. 2002 Sep-Oct;31(5):374-81. doi: 10.1067/mhl.2002.127941. Heart Lung. 2002. PMID: 12487016

5

Longitudinal changes in airflow limitation and airway hyperresponsiveness in patients with stable asthma.

Oga T, Nishimura K, Tsukino M, Hajiro T, Sato S, Ikeda A, Hamada C, Mishima M. Oga T, et al. Ann Allergy Asthma Immunol. 2002 Dec;89(6):619-25. doi: 10.1016/S1081-1206(10)62111-4. Ann Allergy Asthma Immunol. 2002. PMID: 12487229

6

A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD.

Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Oga T, et al. Chest. 2003 Jun;123(6):1810-6. doi: 10.1378/chest.123.6.1810. Chest. 2003. PMID: 12796154 Clinical Trial.

7

A comparison of the responsiveness of different generic health status measures in patients with asthma.

Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Oga T, et al. Qual Life Res. 2003 Aug;12(5):555-63. doi: 10.1023/a:1025051829223. Qual Life Res. 2003. PMID: 13677500

8

Optimal cutoff level of breath carbon monoxide for assessing smoking status in patients with asthma and COPD.

Sato S, Nishimura K, Koyama H, Tsukino M, Oga T, Hajiro T, Mishima M. Sato S, et al. Among authors: oga t. Chest. 2003 Nov;124(5):1749-54. doi: 10.1378/chest.124.5.1749. Chest. 2003. PMID: 14605044

9

Possible maximal change in the SF-36 of outpatients with chronic obstructive pulmonary disease and asthma.

Sato S, Nishimura K, Tsukino M, Oga T, Hajiro T, Ikeda A, Mishima M. Sato S, et al. Among authors: oga t. J Asthma. 2004;41(3):355-65. doi: 10.1081/jas-120026095. J Asthma. 2004. PMID: 15260470

10

Longitudinal changes in health status using the chronic respiratory disease questionnaire and pulmonary function in patients with stable chronic obstructive pulmonary disease.

Oga T, Nishimura K, Tsukino M, Hajiro T, Sato S, Ikeda A, Hamadas C, Mishima M. Oga T, et al. Qual Life Res. 2004 Aug;13(6):1109-16. doi: 10.1023/B:QURE.0000031345.56580.6a. Qual Life Res. 2004. PMID: 15287277

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters